Improving cardiovascular clinical trials conduct in the United States: recommendation from clinicians, researchers, sponsors, and regulators

American Heart Journal
Javed ButlerMihai Gheorghiade

Abstract

Advances in medical therapies leading to improved patient outcomes are in large part related to successful conduct of clinical trials that offer critical information regarding the efficacy and safety of novel interventions. The conduct of clinical trials in the United States, however, continues to face increasing challenges with recruitment and retention. These trends are paralleled by an increasing shift toward more multinational trials where most participants are enrolled in countries outside the United States, bringing into question the generalizability of the results to the American population. This manuscript presents the perspectives and recommendations from clinicians, researchers, sponsors, and regulators who attended a meeting facilitated by the Food and Drug Administration to improve upon the current clinical trial trends in the United States.

References

Nov 25, 2003·Nature Reviews. Genetics·David B GoldsteinSanjay M Sisodiya
Oct 13, 2004·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Salim Yusuf
Jan 13, 2006·JAMA : the Journal of the American Medical Association·Deepak L BhattUNKNOWN REACH Registry Investigators
Sep 30, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David M Dilts, Alan B Sandler
Mar 27, 2007·JAMA : the Journal of the American Medical Association·Mihai GheorghiadeUNKNOWN Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators
Feb 21, 2009·The New England Journal of Medicine·Seth W GlickmanKevin A Schulman
Feb 27, 2009·JAMA : the Journal of the American Medical Association·Pierluigi TricociSidney C Smith
Jun 26, 2009·The New England Journal of Medicine·John R Adler
Jul 3, 2010·Clinical Trials : Journal of the Society for Clinical Trials·Anneke T SchroenCraig L Slingluff
Nov 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David M DiltsJames H Doroshow
Feb 18, 2011·JAMA : the Journal of the American Medical Association·David L DeMets, Robert M Califf
Aug 20, 2011·Journal of the American College of Cardiology·Christopher M O'ConnorMichael R Bristow
Mar 28, 2012·Journal of Pain & Palliative Care Pharmacotherapy·UNKNOWN Institute of Medicine
Sep 18, 2012·American Heart Journal·Robert J MentzChristopher M O'Connor
Sep 21, 2012·The New England Journal of Medicine·Aaron S KesselheimJerry Avorn
Nov 3, 2012·JAMA : the Journal of the American Medical Association·Robert M CaliffMarie Lynn Miranda
Jun 19, 2013·Journal of the National Cancer Institute·Jeffrey S AbramsJames H Doroshow
Sep 3, 2013·The New England Journal of Medicine·Michael S Lauer, Ralph B D'Agostino
Nov 15, 2013·The New England Journal of Medicine·David GordonMichael S Lauer
Nov 15, 2013·The New England Journal of Medicine·P J Devereaux, Salim Yusuf
Nov 19, 2013·JAMA : the Journal of the American Medical Association·Robert M Califf, Richard Platt
Jan 3, 2014·The New England Journal of Medicine·Justin ChakmaReshma Jagsi
Mar 14, 2014·JACC. Heart Failure·Christopher O'Connor
Apr 10, 2014·JAMA : the Journal of the American Medical Association·Zubin J EapenRobert J Temple
Apr 11, 2014·The New England Journal of Medicine·Bertram PittUNKNOWN TOPCAT Investigators
May 29, 2014·European Journal of Heart Failure·Bertram Pitt, Mihai Gheorghiade
Jul 10, 2014·The New England Journal of Medicine·Marc A PfefferSonja M McKinlay

❮ Previous
Next ❯

Citations

Nov 26, 2015·The Journal of Steroid Biochemistry and Molecular Biology·Michael SchumacherRachida Guennoun
Sep 1, 2015·Drug Delivery and Translational Research·Rodney J Y HoJingwei Shao
Jul 16, 2015·Contemporary Clinical Trials·Carmen RosaErin L Winstanley
Oct 16, 2015·Heart Failure Clinics·Stephen J GreeneRobert J Mentz
Oct 16, 2015·Heart Failure Clinics·Lauren B CooperG Michael Felker
Aug 25, 2015·American Heart Journal·Javed ButlerMihai Gheorghiade
Feb 5, 2015·Heart Failure Reviews·Matthew E HarinsteinMihai Gheorghiade
Mar 2, 2017·Current Heart Failure Reports·Lars H LundStefan James
Jan 10, 2018·European Journal of Heart Failure·Muthiah VaduganathanJaved Butler
Jun 19, 2016·Journal of the American Heart Association·Louis A KerkhoffNeal W Dickert
Sep 15, 2016·Circulation. Heart Failure·John J V McMurray
Nov 7, 2017·Clinical Pharmacology and Therapeutics·Julie T WattersAdil E Bharucha
Nov 24, 2020·Current Treatment Options in Cardiovascular Medicine·Sujana BallaFatima Rodriguez
Mar 31, 2017·Circulation. Heart Failure·Javed ButlerMihai Gheorghiade

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Carolyn C Gotay
Journal of the Association for Academic Minority Physicians : the Official Publication of the Association for Academic Minority Physicians
M S Johnson
Journal of General Internal Medicine
George Z Retsch-BogartBonnie W Ramsey
© 2022 Meta ULC. All rights reserved